Literature DB >> 3600604

Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.

A Goldstein, R W Barrett.   

Abstract

The dissociation constant of a ligand at a binding site (e.g., receptor, antibody) is often determined indirectly by competitive displacement of a radioligand. It is well known that such a determination may be seriously in error unless the free concentrations of both the radioligand and the unlabeled ligand can be measured. By means of computer simulations we have explored the conditions under which this error may occur and its magnitude. We offer guidelines for recognizing a probably inaccurate dissociation constant, and we show how, in some cases, a correction can be made. The problem addressed here is not only a theoretical one; it can arise in the ordinary performance of competition binding assays.

Mesh:

Substances:

Year:  1987        PMID: 3600604

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

Review 1.  Matching models to data: a receptor pharmacologist's guide.

Authors:  David A Hall; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins.

Authors:  D Blakeley; D A Sykes; P Ensor; E Bertran; P J Aston; S J Charlton
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

3.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

4.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  "DAKLI": a multipurpose ligand with high affinity and selectivity for dynorphin (kappa opioid) binding sites.

Authors:  A Goldstein; J J Nestor; A Naidu; S R Newman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 6.  Ligand binding assays at equilibrium: validation and interpretation.

Authors:  Edward C Hulme; Mike A Trevethick
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

7.  Ligands of thermophilic ABC transporters encoded in a newly sequenced genomic region of Thermotoga maritima MSB8 screened by differential scanning fluorimetry.

Authors:  Nathalie Boucher; Kenneth M Noll
Journal:  Appl Environ Microbiol       Date:  2011-07-15       Impact factor: 4.792

8.  Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.

Authors:  L Negri; G F Erspamer; C Severini; R L Potenza; P Melchiorri; V Erspamer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Substrate adaptabilities of Thermotogae mannan binding proteins as a function of their evolutionary histories.

Authors:  Nathalie Boucher; Kenneth M Noll
Journal:  Extremophiles       Date:  2016-07-25       Impact factor: 2.395

10.  Ligand depletion in vivo modulates the dynamic range and cooperativity of signal transduction.

Authors:  Stuart J Edelstein; Melanie I Stefan; Nicolas Le Novère
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.